Correlation Between China Pharma and China SXT

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both China Pharma and China SXT at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining China Pharma and China SXT into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between China Pharma Holdings and China SXT Pharmaceuticals, you can compare the effects of market volatilities on China Pharma and China SXT and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in China Pharma with a short position of China SXT. Check out your portfolio center. Please also check ongoing floating volatility patterns of China Pharma and China SXT.

Diversification Opportunities for China Pharma and China SXT

0.26
  Correlation Coefficient

Modest diversification

The 3 months correlation between China and China is 0.26. Overlapping area represents the amount of risk that can be diversified away by holding China Pharma Holdings and China SXT Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on China SXT Pharmaceuticals and China Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on China Pharma Holdings are associated (or correlated) with China SXT. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of China SXT Pharmaceuticals has no effect on the direction of China Pharma i.e., China Pharma and China SXT go up and down completely randomly.

Pair Corralation between China Pharma and China SXT

Given the investment horizon of 90 days China Pharma Holdings is expected to under-perform the China SXT. But the stock apears to be less risky and, when comparing its historical volatility, China Pharma Holdings is 1.34 times less risky than China SXT. The stock trades about -0.08 of its potential returns per unit of risk. The China SXT Pharmaceuticals is currently generating about -0.05 of returns per unit of risk over similar time horizon. If you would invest  1,750  in China SXT Pharmaceuticals on August 24, 2024 and sell it today you would lose (1,712) from holding China SXT Pharmaceuticals or give up 97.83% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

China Pharma Holdings  vs.  China SXT Pharmaceuticals

 Performance 
       Timeline  
China Pharma Holdings 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Weak
Over the last 90 days China Pharma Holdings has generated negative risk-adjusted returns adding no value to investors with long positions. Despite fairly strong technical indicators, China Pharma is not utilizing all of its potentials. The latest stock price confusion, may contribute to short-horizon losses for the traders.
China SXT Pharmaceuticals 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days China SXT Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unfluctuating performance in the last few months, the Stock's basic indicators remain rather sound which may send shares a bit higher in December 2024. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders.

China Pharma and China SXT Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with China Pharma and China SXT

The main advantage of trading using opposite China Pharma and China SXT positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if China Pharma position performs unexpectedly, China SXT can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in China SXT will offset losses from the drop in China SXT's long position.
The idea behind China Pharma Holdings and China SXT Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.

Other Complementary Tools

Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins